Advertisement
News
Advertisement

Momenta hits Teva with IP lawsuit

Fri, 12/03/2010 - 8:24pm
Medical Design Technology

Momenta Pharmaceuticals Inc. has filed a lawsuit against Teva Pharmaceutical Industries Ltd. alleging two cases of patent infringement, according to a Momenta press release. The suit was filed in the U.S. District Court for the District of Massachusetts.

The affected patents relate to Momenta’s IP in making enoxaparin sodium, a generic version of Lovenox, Sanofi-aventis’ name-brand treatment for prevent blood clots in the leg. One patent covers the processing of the drug and the other covers the analysis methods of the drug. 

SOURCE

SOURCE

Topics

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading